Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: A structure-guided study of OXA-24 and OXA-48
Lahiri, S. D.; Mangani, S.; Jahić, H.et al.
2015 • In ACS Chemical Biology, 10 (2), p. 591-600
Lahiri, S. D.; Infection Biosciences, AstraZeneca R and D Boston, Waltham, MA 02451, United States
Mangani, S.; Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Siena, I-53100, Italy
Jahić, H.; Infection Biosciences, AstraZeneca R and D Boston, Waltham, MA 02451, United States
Benvenuti, M.; Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Siena, I-53100, Italy
Durand-Reville, T. F.; Infection Chemistry, AstraZeneca R and D Boston, Waltham, MA 02451, United States
De Luca, F.; Department of Medical Biotechnologies, University of Siena, Siena, I-53100, Italy
Ehmann, D. E.; Infection Biosciences, AstraZeneca R and D Boston, Waltham, MA 02451, United States
Rossolini, G. M.; Department of Medical Biotechnologies, University of Siena, Siena, I-53100, Italy, Department of Experimental and Clinical Medicine, University of Florence, Florence, I-50134, Italy, Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, I-50134, Italy
Alm, R. A.; Infection Biosciences, AstraZeneca R and D Boston, Waltham, MA 02451, United States
Docquier, Jean-Denis ; Université de Liège - ULiège > Département des sciences de la vie > Centre d'ingénierie des protéines
Language :
English
Title :
Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: A structure-guided study of OXA-24 and OXA-48
Bush, K. and Bradford, P. A. (2007) β-Lactamases: Historical perspectives. In Enzyme-Mediated Resistance to Antibiotics: Mechanisms, Dissemination, and Prospects for Inhibition; pp 67-79; (Bonomo, R. A. and Tolmasky, M. E., Eds.) American Society for Microbiology Press, Washington, DC.
Carlet, J. (2013) Multi-drug resistant bacteria and antibiotics Rev. Infirm. 192, 17-19
Bassetti, M., Merelli, M., Temperoni, C., and Astilean, A. (2013) New antibiotics for bad bugs: Where are we? Ann. Clin. Microbiol. Antimicrob. 12, 22
Patel, G. and Bonomo, R. A. (2013) "Stormy waters ahead": Global emergence of carbapenemases Front. Microbiol. 4, 48
Waley, S. G. (1992) β-Lactamase: Mechanisms of Action. In The Chemistry of β-Lactams; pp 198-228; (Page, M. I., Ed.) Chapman and Hall, London.
Pratt, R. F. (1992) β Lactamase: In The Chemistry of β-Lactams; pp 229-271; (Page, M. I., Ed.) Chapman and Hall, London.
Bush, K. and Jacoby, G. A. (2010) Updated functional classification of β-lactamases Antimicrob. Agents Chemother. 54, 969-976
Evans, B. A. and Amyes, S. G. (2014) OXA β-lactamases Clin. Microbiol. Rev. 27, 241-263
Poirel, L., Naas, T., and Nordmann, P. (2010) Diversity, epidemiology, and genetics of class D β-lactamases Antimicrob. Agents Chemother. 54, 24-38
Li, J., Cross, J. B., Vreven, T., Meroueh, S. O., Mobashery, S., and Schlegel, H. B. (2005) Lysine carboxylation in proteins: OXA-10 β-lactamase Proteins: Struct., Funct., Bioinf. 61, 246-257
Schneider, K. D., Ortega, C. J., Renck, N. A., Bonomo, R. A., Powers, R. A., and Leonard, D. A. (2011) Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem J. Mol. Biol. 406, 583-594
Docquier, J. D., Calderone, V., De Luca, F., Benvenuti, M., Giuliani, F., Bellucci, L., Tafi, A., Nordmann, P., Botta, M., Rossolini, G. M., and Mangani, S. (2009) Crystal structure of the OXA-48 β-lactamase reveals mechanistic diversity among class D carbapenemases Chem. Biol. 16, 540-547
Drawz, S. M., Papp-Wallace, K. M., and Bonomo, R. A. (2014) New β-lactamase inhibitors: A therapeutic renaissance in an MDR world Antimicrob. Agents Chemother. 58, 1835-1846
Shlaes, D. M. (2013) New β-lactam-β-lactamase inhibitor combinations in clinical development Ann. N.Y. Acad. Sci. 1277, 105-114
Ehmann, D. E., Jahic, H., Ross, P. L., Gu, R. F., Hu, J., Kern, G., Walkup, G. K., and Fisher, S. L. (2012) Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor Proc. Natl. Acad. Sci. U.S.A. 109, 11663-11668
Ehmann, D. E., Jahic, H., Ross, P. L., Gu, R. F., Hu, J., Durand-Reville, T. F., Lahiri, S., Thresher, J., Livchak, S., Gao, N., Palmer, T., Walkup, G. K., and Fisher, S. L. (2013) Kinetics of avibactam inhibition against class A, C, and D β-lactamases J. Biol. Chem. 288, 27960-27971
Lagace-Wiens, P., Walkty, A., and Karlowsky, J. A. (2014) Ceftazidime/avibactam: An evidence-based review of its pharmacology and potential use in the treatment of gram-negative bacterial infections Core Evid. 9, 13-25
Aktas, Z., Kayacan, C., and Oncul, O. (2012) In vitro activity of avibactam (NXL104) in combination with β-lactams against gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae Int. J. Antimicrob. Agents 39, 86-89
Porres-Osante, N., de Champs, C., Dupont, H., Torres, C., and Mammeri, H. (2014) Use of avibactam to detect ambler class A carbapenemases and OXA-48 β-lactamases in Enterobacteriaceae Diagn. Microbiol. Infect. Dis. 79, 399-400
Lahiri, S. D., Mangani, S., Durand-Reville, T., Benvenuti, M., De Luca, F., Sanyal, G., and Docquier, J. D. (2013) Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: Avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases Antimicrob. Agents Chemother. 57, 2496-2505
Lahiri, S. D., Johnstone, M., Ross, P. L., McLaughlin, R., Olivier, N. B., and Alm, R. A. (2014) Avibactam and class C β-lactamases: Mechanism of inhibition, conservation of binding pocket and implications for resistance Antimicrob. Agents Chemother. 58, 5704-13
Xu, H., Hazra, S., and Blanchard, J. S. (2012) NXL104 irreversibly inhibits the β-lactamase from Mycobacterium tuberculosis Biochemistry 22, 4551-4557
Emsley, P. and Cowtan, K. (2004) Coot: Model-building tools for molecular graphics Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G., McCoy, A., McNicholas, S. J., Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read, R. J., Vagin, A., and Wilson, K. S. (2011) Overview of the CCP4 suite and current developments Acta Crystallogr., Sect. D: Biol. Crystallogr. 67, 235-242
Debreczeni, J. E. and Emsley, P. (2012) Handling ligands with coot Acta Crystallogr., Sect. D: Biol. Crystallogr. 68, 425-430
Santillana, E., Beceiro, A., Bou, G., and Romero, A. (2007) Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis Proc. Natl. Acad. Sci. U.S.A. 104, 5354-5359
Goldenberg, O., Erez, E., Nimrod, G., and Ben-Tal, N. (2009) The ConSurf-DB: Pre-calculated evolutionary conservation profiles of protein structures Nucleic Acids Res. 37, D323-7
DeLano, W. L. The PyMOL Molecular Graphics System; Schrodinger, LLC, New York. See http://www.pymol.org/.
De Luca, F., Benvenuti, M., Carboni, F., Pozzi, C., Rossolini, G. M., Mangani, S., and Docquier, J. D. (2011) Evolution to carbapenem-hydrolyzing activity in noncarbapenemase class D β-lactamase OXA-10 by rational protein design Proc. Natl. Acad. Sci. U.S.A. 108, 18424-18429
Kaitany, K. C., Klinger, N. V., June, C. M., Ramey, M. E., Bonomo, R. A., Powers, R. A., and Leonard, D. A. (2013) Structures of the class D carbapenemases OXA-23 and OXA-146: Mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam Antimicrob. Agents Chemother. 57, 4848-4855
Smith, C. A., Antunes, N. T., Stewart, N. K., Toth, M., Kumarasiri, M., Chang, M., Mobashery, S., and Vakulenko, S. B. (2013) Structural basis for carbapenemase activity of the OXA-23 β-lactamase from Acinetobacter baumannii Chem. Biol. 20, 1107-1115
Che, T., Bethel, C. R., Pusztai-Carey, M., Bonomo, R. A., and Carey, P. R. (2014) The different inhibition mechanisms of OXA-1 and OXA-24 β-lactamases are determined by the stability of active site carboxylated lysine J. Biol. Chem. 289, 6152-6164
Che, T., Bonomo, R. A., Shanmugam, S., Bethel, C. R., Pusztai-Carey, M., Buynak, J. D., and Carey, P. R. (2012) Carboxylation and decarboxylation of active site lys 84 controls the activity of OXA-24 β-lactamase of Acinetobacter baumannii: Raman crystallographic and solution evidence J. Am. Chem. Soc. 134, 11206-11215
June, C. M., Vallier, B. C., Bonomo, R. A., Leonard, D. A., and Powers, R. A. (2014) Structural origins of oxacillinase specificity in class D β-lactamases Antimicrob. Agents Chemother. 58, 333-341
Perichon, B., Goussard, S., Walewski, V., Krizova, L., Cerqueira, G., Murphy, C., Feldgarden, M., Wortman, J., Clermont, D., Nemec, A., and Courvalin, P. (2014) Identification of 50 class D β-lactamases and 65 Acinetobacter -derived cephalosporinases in Acinetobacter spp Antimicrob. Agents Chemother. 58, 936-949
Poirel, L., Potron, A., and Nordmann, P. (2012) OXA-48-like carbapenemases: The phantom menace J. Antimicrob. Chemother. 67, 1597-1606